Sort
48,018 grants matching “immunotherapy”
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$527,973Howard C Crawford · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$527,973Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
BALANCING T-CELL FUNCTION AND METABOLISM FOR IMMUNOTHERAPY
$527,921University Of Houston System · · FY2017 · Department of the Army
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
$527,915Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2020 · NS
DISARMing the immunological barriers to regeneration in mammals
$527,871James W Godwin · Jackson Laboratory · R01 · FY2023 · HD
Targeting immunosuppression of intratumoral CAR T cells
$527,840Serge Y Fuchs · University Of Pennsylvania · R01 · FY2024 · CA
Mechanisms of Hepatitis C Virus Evolution
$527,839Stuart C Ray · Johns Hopkins University · R01 · FY2010 · DA
The role of natural killer cells and antibodies in protection from malaria
$527,817Geoffrey T Hart · University Of Minnesota · R01 · FY2022 · AI
Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
$527,817Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2022 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$527,799Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2019 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2020 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2021 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2023 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$527,746Gordon B. Mills · Oregon Health & Science University · U01 · FY2025 · CA
Translation of commensal bacteria mechanism for immunotherapy
$527,560Howard C Hang · Scripps Research Institute, The · R01 · FY2024 · CA
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
$527,544Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2022 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2025 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2022 · CA
Targeted Therapies for Lymphoid Malignancies
$527,476Jennifer A. Woyach · Ohio State University · R01 · FY2022 · CA
Targeted Therapies for Lymphoid Malignancies
$527,476Jennifer A. Woyach · Ohio State University · R01 · FY2023 · CA
Core B: Computational
$527,419Alan S Perelson · Boston College · P01 · FY2021 · AI
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials
$527,385Martin John Hessner · Medical College Of Wisconsin · R01 · FY2021 · DK
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials
$527,385Martin John Hessner · Medical College Of Wisconsin · R01 · FY2022 · DK
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$527,355Anant Madabhushi · Emory University · R01 · FY2025 · CA